Precigen Inc. (NASDAQ: PGEN) is -10.39% lower on its value in year-to-date trading and has touched a low of $1.26 and a high of $11.10 in the current 52-week trading range. The PGEN stock was last observed hovering at around $9.14 in the last trading session, with the day’s loss setting it -0.54% off its average median price target of $10.00 for the next 12 months. It is also 33.85% off the consensus price target high of $13.00 offered by 3 analysts, but current levels are -43.33% lower than the price target low of $6.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $8.60, the stock is -9.01% and 4.69% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.25 million and changing -5.85% at the moment leaves the stock 65.55% off its SMA200. PGEN registered 55.31% gain for a year compared to 6-month gain of 92.02%. The firm has a 50-day simple moving average (SMA 50) of $9.07 and a 200-day simple moving average (SMA200) of $5.95.
The stock witnessed a -5.09% loss in the last 1 month and extending the period to 3 months gives it a 101.77%, and is 8.55% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.11% over the week and 9.26% over the month.
Precigen Inc. (PGEN) has around 770 employees, a market worth around $1.82B and $92.20M in sales. Distance from 52-week low is 582.94% and -22.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-69.70%).
Precigen Inc. (PGEN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Precigen Inc. (PGEN) is a “Overweight”. 3 analysts offering their recommendations for the stock have an average rating of 2.30, where 1 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Precigen Inc. is expected to release its quarterly report on 05/12/2021 and quarterly earnings per share for the current quarter are estimated at -$0.14 with sales reaching $22.22M over the same period.The EPS is expected to grow by 57.60% this year, but quarterly earnings will post 17.00% year-over-year. Quarterly sales are estimated to grow 30.70% in year-over-year returns.
Precigen Inc. (PGEN) Top Institutional Holders
216 institutions hold shares in Precigen Inc. (PGEN), with 34.02M shares held by insiders accounting for 18.34% while institutional investors hold 80.81% of the company’s shares. The shares outstanding are 165.53M, and float is at 155.35M with Short Float at 15.83%. Institutions hold 65.99% of the Float.
The top institutional shareholder in the company is Third Security, LLC with over 84.02 million shares valued at $294.07 million. The investor’s holdings represent 45.30% of the PGEN Shares outstanding. As of Sep 29, 2020, the second largest holder is Miller Value Partners, LLC with 7.56 million shares valued at $26.46 million to account for 4.08% of the shares outstanding. The other top investors are Blackrock Inc. which holds 6.98 million shares representing 3.76% and valued at over $24.43 million, while Vanguard Group, Inc. (The) holds 3.66% of the shares totaling 6.79 million with a market value of $23.78 million.
Precigen Inc. (PGEN) Insider Activity
A total of 44 insider transactions have happened at Precigen Inc. (PGEN) in the last six months, with sales accounting for 15 and purchases happening 29 times. The most recent transaction is an insider sale by Sabzevari Helen, the company’s President and CEO. SEC filings show that Sabzevari Helen sold 260,045 shares of the company’s common stock on Jan 06 at a price of $8.92 per share for a total of $2.32 million. Following the sale, the insider now owns 0.66 million shares.
Precigen Inc. disclosed in a document filed with the SEC on Jan 05 that Sterling Rick L. (Chief Financial Officer) sold a total of 6,096 shares of the company’s common stock. The trade occurred on Jan 05 and was made at $10.56 per share for $64404.0. Following the transaction, the insider now directly holds 0.34 million shares of the PGEN stock.
Still, SEC filings show that on Jan 05, Sabzevari Helen (President and CEO) disposed off 9,040 shares at an average price of $10.56 for $95507.0. The insider now directly holds 415,259 shares of Precigen Inc. (PGEN).